An interventional study of Gamified education in Chemotherapy, Sun Protection and Self Efficacy, sponsored by Lokman Hekim University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-10.
Sponsored by Lokman Hekim University · Not applicable, Interventional, and Health services research
Chemotherapy may cause photosensitivity and other skin reactions that can negatively affect patients' comfort, quality of life, and adherence to treatment. Appropriate sun protection behaviors are therefore important for patients receiving chemotherapy.
This randomized controlled trial aims to evaluate the effect of gamified sun protection education on sun protection self-efficacy and sun protection behaviors in patients receiving chemotherapy.
A total of 54 patients will be randomly assigned to two groups, with 27 participants in each group. Participants in the intervention group will receive gamified sun protection education, while participants in the control group will receive usual care. The educational intervention will be delivered over a two-week period.
Sun protection self-efficacy and sun protection behaviors will be assessed at baseline and after completion of the two-week intervention.
481 studies on the registry are indexed under Health Education; 110 are open to participants now.
This study's planned enrollment of 54 is below the median of 132 across 450 interventional studies indexed under Health Education.
Browse Health Education studies →Lokman Hekim University is the lead sponsor of 43 studies on the registry; 17 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
-Receiving radiotherapy concurrently with chemotherapy
Behavioral: Gamified education
Gamified education
Change in Sun Protection Self-Efficacy Scale Total Score
Sun protection self-efficacy will be assessed using the Sun Protection Self-Efficacy Scale. The outcome will be the change in the total scale score from baseline to the end of the 2-week intervention. Higher scores indicate greater self-efficacy regarding sun protection behaviors.
Time frame: Baseline and immediately after completion of the 2-week intervention
Change in Sun Protection Behavior Scale Total Score
Sun protection behaviors will be assessed using the Sun Protection Behavior Scale. The outcome will be the change in the total scale score from baseline to the end of the 2-week intervention. Higher scores indicate greater engagement in sun protection behaviors.
Time frame: Baseline and immediately after completion of the 2-week intervention
Plan to share: No — Individual participant data (IPD) are not planned to be shared.
No publications or documents are linked to this record.
Start is estimated for Sep 2026; primary completion for Nov 2026, 2 months later.
Of 292 non-industry interventional studies with no phase under Health Education, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 24. This study's planned 2 months is below that.
Counting every sponsor, half of 293 studies reached it within 11 months; a quarter within 3 and three quarters within 24.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Lokman Hekim University